Cargando…
Optimal management of prostate cancer with lethal biology – state-of-the-art local therapy
Defining prostate cancer with lethal biology based upon clinical criteria is challenging. Locally advanced/High-Grade prostate cancer can be downstaged or even downgraded with cure in up to 60% of patients with primary therapy.12345 However, what is known is that high-grade prostate cancers have a g...
Autor principal: | Chapin, Brian F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4814949/ https://www.ncbi.nlm.nih.gov/pubmed/26178396 http://dx.doi.org/10.4103/1008-682X.156855 |
Ejemplares similares
-
Perspectives on the clinical management of localized prostate cancer
por: Nelson, Joel B
Publicado: (2014) -
Therapy decisions for the symptomatic patient with metastatic castration-resistant prostate cancer
por: Markowski, Mark C, et al.
Publicado: (2015) -
Testosterone therapy: a friend or a foe for the aging men with benign prostatic hyperplasia?
por: Rastrelli, Giulia, et al.
Publicado: (2019) -
The Xu's chart for prostate biopsy: a visual presentation of the added value of biomarkers to prostate-specific antigen for estimating detection rates of prostate cancer
por: Xu, Jianfeng
Publicado: (2014) -
Active surveillance for prostate cancer: when to recommend delayed intervention
por: Babaian, Kara N
Publicado: (2015)